DrugPatentWatch Database Preview
Taliglucerase alfa - Biologic Drug Details
» See Plans and Pricing
Summary for taliglucerase alfa
| Tradenames: | 1 |
| Patents: | 4 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for taliglucerase alfa |
Recent Clinical Trials for taliglucerase alfa
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Ari Zimran | Phase 4 |
| Pfizer | Phase 4 |
| Protalix | Phase 4 |
Patent Text Search: US Patents for taliglucerase alfa
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | ELELYSO | taliglucerase alfa | POWDER;INTRAVENOUS | 022458 | 001 | 2014-01-13 | Start Trial | 2039-02-26 | RX | Orphan | search | |
| Pfizer | ELELYSO | taliglucerase alfa | POWDER;INTRAVENOUS | 022458 | 001 | 2014-01-13 | Start Trial | 2039-02-26 | RX | Orphan | search | |
| Pfizer | ELELYSO | taliglucerase alfa | POWDER;INTRAVENOUS | 022458 | 001 | 2014-01-13 | Start Trial | 2036-02-11 | RX | Orphan | search | |
| Pfizer | ELELYSO | taliglucerase alfa | POWDER;INTRAVENOUS | 022458 | 001 | 2014-01-13 | Start Trial | Selecta Biosciences, Inc. (Watertown, MA) | 2033-05-03 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for taliglucerase alfa
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2935172 | Start Trial |
| South Korea | 20170105538 | Start Trial |
| Australia | 2015375444 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017138971 | Start Trial |
| Japan | 2018504942 | Start Trial |
| China | 108473231 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
